Microbiology of bile aspirates obtained at ERCP in patients with suspected acute cholangitis

Abstract

Background The cornerstone of treatment for acute cholangitis is source control with biliary drainage and early antibiotics. The primary aim of this study was to describe the microbiology of bile aspirate pathogens obtained at the time of endoscopic retrograde cholangiopancreatography (ERCP) in patients suspected of having acute cholangitis.

Methods In this single-center retrospective study, patients were included if a bile aspirate was collected at ERCP for suspicion of acute cholangitis, from 1 January 2010 to 31 December 2016.

Results There were 721 ERCP procedures for suspected acute cholangitis with bile culture results, with 662 positive bile cultures (91.8 %). Pathogens included: Enterococcus species (spp.) 448 (67.7 %); Klebsiella spp. 295 (44.6 %); Escherichia coli 269 (40.6 %); Pseudomonas spp. 52 (7.9 %); and anaerobes 64 (9.7 %). Susceptibility of Klebsiella pneumoniae and E.coli isolates to ciprofloxacin was 88 % and 64 %, respectively. Extended-spectrum beta-lactamases and carbapenem resistance were found in 7.9 % and 3.6 % of Enterobacteriaceae, respectively. There were 437 concurrent blood cultures, of which 174 were positive (39.8 % of cultures drawn). Prior biliary endoscopic sphincterotomy (ES) was evident in 459 ERCP cases (63.7 %), and was associated with increased frequency of Klebsiella spp., Pseudomonas aeruginosa, Enterobacter spp., and Enterococcus spp. Prior biliary ES significantly increased the probability of vancomycin-resistant Enterococcus (VRE).

Conclusions The vast majority of bile cultures (91.8 %) were positive. The susceptibilities of E.coli and K.pneumoniae to ciprofloxacin are lower than historically noted. A notable portion of cultures contained pathogenic drug-resistant organisms. Prior biliary ES is associated with a higher frequency of certain organisms and higher frequency of VRE.

^* Joint first authors

Publication History

Received: 26 April 2020

Accepted after revision: 04 March 2022

Accepted Manuscript online:
07 March 2022

Article published online:
03 June 2022

• References

• 1 Saik RP, Greenburg AG, Farris JM. et al. Spectrum of cholangitis. Am J Surg 1975; 130: 143-150
• 2 Miura F, Okamoto K, Takada T. et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci 2018; 25: 31-40
• 3 Rhodes A, Evans LE, Alhazzani W. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med 2017; 45: 486-552
• 4 van den Hazel SJ, Speelman P, Tytgat GN. et al. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis 1994; 19: 279-286
• 5 Lai EC, Mok FP, Tan ES. et al. Endoscopic biliary drainage for severe acute cholangitis. NEJM 1992; 326: 1582-1586
• 6 Park CS, Jeong HS, Kim KB. et al. Urgent ERCP for acute cholangitis reduces mortality and hospital stay in elderly and very elderly patients. Hepatobiliary Pancreat Dis Int 2016; 15: 619-625
• 7 Khashab MA, Tariq A, Tariq U. et al. Delayed and unsuccessful endoscopic retrograde cholangiopancreatography are associated with worse outcomes in patients with acute cholangitis. Clin Gastroenterol Hepatol 2012; 10: 1157-1161
• 8 Leese T, Neoptolemos JP, Baker AR. et al. Management of acute cholangitis and the impact of endoscopic sphincterotomy. Br J Surg 1986; 73: 988-992
• 9 Sugiyama M, Atomi Y. Treatment of acute cholangitis due to choledocholithiasis in elderly and younger patients. Arch Surg 1997; 132: 1129-1133
• 10 Tan M, Schaffalitzky de Muckadell OB, Laursen SB. Association between early ERCP and mortality in patients with acute cholangitis. Gastrointest Endosc 2018; 87: 185-192
• 11 Xu MM, Carr-Locke DL. Early ERCP for severe cholangitis? Of course! . Gastrointest Endosc 2018; 87: 193-195
• 12 Rerknimitr R, Fogel EL, Kalayci C. et al. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc 2002; 56: 885-889
• 13 Mazuski JE, Tessier JM, May AK. et al. The Surgical Infection Society revised guidelines on the management of intra-abdominal infection. Surg Infect 2017; 18: 1-76
• 14 Yahav D, Franceschini E, Koppel F. et al. Seven versus fourteen days of antibiotic therapy for uncomplicated gram-negative bacteremia: a non-inferiority randomized controlled trial. Clin Infect Dis 2019; 69: 1091-1098
• 15 Perez KK, Olsen RJ, Musick WL. et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect 2014; 69: 216-225
• 16 Uno S, Hase R, Kobayashi M. et al. Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia. Int J Infect Dis 2017; 55: 81-85
• 17 Rex DK, Sieber M, Lehman GA. et al. A double-reprocessing high-level disinfection protocol does not eliminate positive cultures from the elevators of duodenoscopes. Endoscopy 2018; 50: 588-596
• 18 US Food and Drug Administration. Supplemental measures to enhance duodenoscope reprocessing: FDA Safety Communication. 2017 Available from (Accessed 30.03.2022): http://wayback.archive-it.org/7993/20170722150658/https:/www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm454766.htm
• 19 US Food and Drug Administration. Olympus validates new reprocessing instructions for model TJF-Q180V duodenoscopes. FDA Safety Communication; 2017 Available from (Accessed 30.03.2022): http://wayback.archive-it.org/7993/20170722213115/https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm439999.htm
• 20 Kozarek R, Hovde O, Attia F. et al. Do pancreatic duct stents cause or prevent pancreatic sepsis?. Gastrointest Endosc 2003; 58: 505-509
• 21 Hashem YA, Amin HM, Essam TM. et al. Biofilm formation in enterococci: genotype-phenotype correlations and inhibition by vancomycin. Sci Rep 2017; 7: 5733
• 22 Lee K, Yoon SS. Pseudomonas aeruginosa biofilm, a programmed bacterial life for fitness. J Microbiol Biotechnol 2017; 27: 1053-1064
• 23 Paterson DL. Resistance in gram-negative bacteria: enterobacteriaceae. Am J Med 2006; 119: S20-S28 discussion S62-S70
• 24 Piperaki ET, Syrogiannopoulos GA, Tzouvelekis LS. et al. Klebsiella pneumoniae: virulence, biofilm and antimicrobial resistance. Pediatr Infect Dis J 2017; 36: 1002-1005
• 25 Reuken PA, Torres D, Baier M. et al. Correction: Risk factors for multi-drug resistant pathogens and failure of empiric first-line therapy in acute cholangitis. PloS One 2017; 12: e0172373
• 26 Solomkin JS, Mazuski JE, Bradley JS. et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 133-164
• 27 Chandra S, Klair JS, Soota K. et al. Endoscopic retrograde cholangio-pancreatography-obtained bile culture can guide antibiotic therapy in acute cholangitis. Dig Dis 2019; 37: 155-160
• 28 Kaya M, Beştaş R, Bacalan F. et al. Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients. World J Gastroenterol 2012; 18: 3585-3589
• 29 Voiosu TA, Bengus A, Haidar A. et al. Antibiotic prophylaxis prior to elective ERCP does not alter cholangitis rates or shorten hospital stay: results of an observational prospective study of 138 consecutive ERCPS. Maedica 2014; 9: 328-332